People with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) may experience fewer acute disease exacerbations if…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Pulmonx has won the green light in Japan to market its Zephyr Endobronchial Valve, a bronchoscope-placed device designed…
A smartphone app developed by Kaia Health to help people with chronic obstructive pulmonary disease (COPD) manage their…
Being exposed to pesticides at work increases the risk of developing chronic obstructive pulmonary disease (COPD), a large U.K.-based…
Patients with moderate-to-very severe chronic obstructive pulmonary disease (COPD) and frequent flare-ups who were given astegolimab, a medicine in…
A first patient has been enrolled in a Phase 4 study of the effectiveness of Yupelri (revefenacin) against Spiriva…
An anti-inflammatory compound used in China to help treat liver disease — known as magnesium isoglycyrrhizinate (MgIG) — eased the…
Low-cost screening involving a questionnaire and a breathing test may help identify patients with undiagnosed chronic obstructive pulmonary disease…
Hemoglobin, the protein that carries oxygen in blood, may be a promising biomarker to assess the clinical outcomes of patients…
Therapeutic Solutions International has filed a patent covering the therapeutic use of JadiCells — a type of mesenchymal stem…